WFDC2 and endometrial cancer: Limitations of our study include the relatively small sample size and lack of data on the molecular subtypes of endometrial cancer, which would have allowed for an exploration of the performance of urine CA125 and HE4 for the detection of specific endometrial cancer molecular phenotypes.